Dec 01, 2017
FDA approves heart protection claims for cholesterol drug evolocumab
Evolocumab the only PCSK9 inhibitor approved to reduce risk of heart attack, stroke and coronary revascularization.
Nov 08, 2017
Reduced blood flow from heart may reduce blood flow in brain’s memory center
Reduced blood flow from heart may age brain 15 to 20 years.
Nov 06, 2017
Depressed with a chronic disease? Consider alternative therapies
Scientists find that commonly prescribed antidepressants aren't effective in people battling both depression and a chronic medical disease, raising a critical question of whether doctors should enact widespread changes in how they treat millions of depressed Americans.
Oct 11, 2017
Hormone therapy may benefit migraine sufferers without increased risk of heart disease
New study reviews WHI data to demonstrate lack of association between migraines, cardiovascular disease, and hormone therapy; opens door to increased use of hormones to treat migraines.
Oct 05, 2017
Newborns with CHD show signs of brain impairment even before cardiac surgery
High-risk newborns have weaker functional connectivity between key regions of their developing brains.
Sep 20, 2017
Researchers discover how to train damaging inflammatory cells to promote repair after stroke
Researchers discover way to temporarily suppress neutrophils and turn them into beneficial weapons that scavenge for toxins, potentially opening a door for a therapeutic approach to hemorrhagic stroke treatment.
Aug 17, 2017
Smoking raises risk of aneurysm recurrence after endovascular treatment
Researchers report people who have experienced an aneurysm have another reason to quit smoking.
Jun 23, 2017
FDA approves betrixaban for venous thromboembolism
The FDA approved betrixaban (BEVYXXA, Portola) for the prophylaxis of venous thromboembolism in adult patients hospitalized for an acute medical illness who are at risk for thromboembolic complications.
May 18, 2017
Researchers connect brain blood vessel lesions to intestinal bacteria
A study in mice and humans suggests that bacteria in the gut can influence the structure of the brain's blood vessels, and may be responsible for producing cerebral cavernous malformations that can lead to stroke or epilepsy.
May 17, 2017
DAWN results show reduction in disability from stroke up to 24 hours of onset
Results from the DAWN stroke trial provide compelling evidence that selected patients suffering a major ischemic stroke recovered significantly better with mechanical retrieval of the blood clot (mechanical thrombectomy) with medical therapy compared with medical therapy alone when initiated past the current guidelines of within 6 hours and up to 24 hours of the stroke.